COVID India Update; 22 States/UTs report Positivity Rate less than National Average

▴ COVID India Update; 22 States/UTs report Positivity Rate less than National Average
For the 17th Day, number of Active Cases below 1 million. There were 971 case fatalities have been reported in the past 24 hours.

India has demonstrated an exponential increase in the COVID-19 testing infrastructure since Jan 2020. The country’s testing capacities have multiplied manifold. More than 15 lakh samples can be tested every day.

India has performed remarkably on fulfilling WHO’s advise of 140 tests/day/ million population. In its Guidance Note on “Public Health Criteria to Adjust Public Health and Social Measures in the Context of COVID-19” WHO has advised this strategy for comprehensive surveillance for suspected cases. 

In another row of achievements, 35 States/UTs have exceeded the advised number of tests. The national average of tests per day per million population stands at 865.

WhatsApp Image 2020-10-08 at 10.19.20 AM.jpeg

Nearly 12 lakh tests were conducted in the last 24 hours in the country. With 11,94,321 tests conducted in the last 24 hours, the cumulative tests have crossed 8.34 crore (8,34,65,975).

As evidence has revealed, higher numbers of testing on a sustained basis have aided in bringing down the positivity rate. The sharp decline in national cumulative positivity rate has demonstrated that the rate of spread of infection is being contained.

Higher testing across wide regions leads to early identification of positive cases, prompt tracking through efficient surveillance and tracing, and timely & effective treatment in homes/facilities and in hospitals for the severe cases. These measures in tandem eventually lead to lower mortality rate.

WhatsApp Image 2020-10-08 at 10.40.52 AM.jpeg

7 States/UTs have reported positivity rate less than 5%.

This is a result of successful TEST, TRACK, TRACE, TREAT and TECHNOLOGY strategy of the Central government effectively followed by States/UTs.

WhatsApp Image 2020-10-08 at 10.27.03 AM.jpeg

 

22 States/UTs have positivity rate less than the national average. The cumulative Positivity Rate is 8.19% and is on a continuous decline.

WhatsApp Image 2020-10-08 at 10.32.25 AM.jpeg

Maintaining the spree of registering more recoveries than the new confirmed cases, 83,011 single day recoveries were registered in last 24 hours as against 78,524 new confirmed cases. The total recovered cases stand at 58,27,704. The gap between Recovered cases and Active cases has crossed 49 lakh (49,25,279).

The Active Cases are less than 10 lakh for the 17th day in a row. Presently the active cases comprise merely 13.20% of the total positive cases of the country standing at 9,02,425.

Higher number of recoveries has aided the national Recovery Rate to further improve to 85.25%.

75% of the new recovered cases are observed to be concentrated in 10 States/UTs. Maharashtra alone has contributed the maximum with more than 16,000 single day recovery.

WhatsApp Image 2020-10-08 at 9.56.01 AM.jpeg

78,524 new confirmed cases were recorded in last 24 hours.

79% of the new cases are from 10 States and UTs. Maharashtra continues to be the State reporting a very high number of new cases with more than 14,000 cases followed by Karnataka with nearly 11,000 cases.

WhatsApp Image 2020-10-08 at 9.56.00 AM (1).jpeg

971 case fatalities have been reported in the past 24 hours.

Of these, nearly 82% are concentrated in ten State/UTs of Maharashtra, Karnataka, Tamil Nadu, West Bengal, Uttar Pradesh, Delhi, Andhra Pradesh, Punjab, Chhattisgarh, and Madhya Pradesh.

More than 36% of new fatalities are reported are from Maharashtra (355 deaths).

WhatsApp Image 2020-10-08 at 9.56.00 AM.jpeg

(PIB release)

Tags : #covidindiaupdate #positivityrate #nationalaverage #positivecases #activecases #indiaupdate #coronavirustesting

Related Stories

18 Jun

FDA approves nasal antihistamine for nonprescription use

Seasonal allergies affect millions causing nasal congestion, runny nose and sneezing. Approval of Asteopro (Azelastine Hydrochloride nasal spray 0.15%) can help many patients with allergies.

View
23 Dec

Glenmark collaborates with Menarini for commercializing Ryaltris nasal spray across Europe

The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain

View
18 Dec

Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals

Research on a novel nasal spray therapy, INNA-051, which has been shown to reduce COVID-19 viral replication by up to 96 percent in a gold standard ferret study, has been published in two leading international peer-reviewed journals.

View
07 Oct

Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the U.S. FDA for Dimethyl Fumarate DR Capsules, the generic version of Tecfidera

View
18 Aug

Glenmark appoints Dipankar Bhattacharjee to its Board of Directors

Glenmark Pharmaceuticals announced the appointment of Mr Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization

View
30 Jul

Food Allergies: All that you have to know

Skin prick testing can in some cases produce bogus negative or bogus positive outcomes.

View
21 May

Cipla receives final approval for Migranal

Cipla receives final approval for generic version of Migranal (Dihydroergotamine Mesylate Nasal Spray) with a Competitive Generic Therapy Designation

View
12 May

Hikma Announces the Launch of Propofol Injectable Emulsion, USP

Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP. Sedative for patients on ventilators currently in short supply in the US

View
28 Feb

Glenmark Pharma Signs an Exclusive Licensing Agreement with Hikma Pharmaceuticals

Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltrisâ„¢ by the US FDA, while Hikma will be responsible for the commercialization of Ryaltrisâ„¢ in the US.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025